BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 28819584)

  • 21. Label-free selection and enrichment of liver cancer stem cells by surface niches build up with polyelectrolyte multilayer films.
    Lee IC; Chang JF
    Colloids Surf B Biointerfaces; 2015 Jan; 125():120-6. PubMed ID: 25461919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of ADAM17 in invasion and migration of CD133-expressing liver cancer stem cells after irradiation.
    Hong SW; Hur W; Choi JE; Kim JH; Hwang D; Yoon SK
    Oncotarget; 2016 Apr; 7(17):23482-97. PubMed ID: 26993601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer stem cells as therapeutic targets of hepato-biliary-pancreatic cancers.
    Tanaka S
    J Hepatobiliary Pancreat Sci; 2015 Jul; 22(7):531-7. PubMed ID: 25874410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. APSA Awardee Submission: Tumor/cancer stem cell marker doublecortin-like kinase 1 in liver diseases.
    Nguyen CB; Houchen CW; Ali N
    Exp Biol Med (Maywood); 2017 Feb; 242(3):242-249. PubMed ID: 27694285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel therapeutic target for cancer stem cells in hepatocellular carcinoma.
    Nagano H; Ishii H; Marubashi S; Haraguchi N; Eguchi H; Doki Y; Mori M
    J Hepatobiliary Pancreat Sci; 2012 Nov; 19(6):600-5. PubMed ID: 22892595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
    Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
    Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biology of hepatic cancer stem cells.
    Tong CM; Ma S; Guan XY
    J Gastroenterol Hepatol; 2011 Aug; 26(8):1229-37. PubMed ID: 21557770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Knock out CD44 in reprogrammed liver cancer cell C3A increases CSCs stemness and promotes differentiation.
    Han S; Guo J; Liu Y; Zhang Z; He Q; Li P; Zhang M; Sun H; Li R; Li Y; Zeng W; Liu J; Lian L; Gao Y; Shen L
    Oncotarget; 2015 Dec; 6(42):44452-65. PubMed ID: 26540347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
    Wang D; Fu L; Sun H; Guo L; DuBois RN
    Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD90 a potential cancer stem cell marker and a therapeutic target.
    Shaikh MV; Kala M; Nivsarkar M
    Cancer Biomark; 2016; 16(3):301-7. PubMed ID: 27062695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating tumor and cancer stem cells in hepatitis C virus-associated liver disease.
    Bahnassy AA; Zekri AR; El-Bastawisy A; Fawzy A; Shetta M; Hussein N; Omran D; Ahmed AA; El-Labbody SS
    World J Gastroenterol; 2014 Dec; 20(48):18240-8. PubMed ID: 25561791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MEK1 signaling promotes self-renewal and tumorigenicity of liver cancer stem cells via maintaining SIRT1 protein stabilization.
    Cheng J; Liu C; Liu L; Chen X; Shan J; Shen J; Zhu W; Qian C
    Oncotarget; 2016 Apr; 7(15):20597-611. PubMed ID: 26967560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel oncolytic adenovirus targeting Wnt signaling effectively inhibits cancer-stem like cell growth via metastasis, apoptosis and autophagy in HCC models.
    Zhang J; Lai W; Li Q; Yu Y; Jin J; Guo W; Zhou X; Liu X; Wang Y
    Biochem Biophys Res Commun; 2017 Sep; 491(2):469-477. PubMed ID: 28698142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relevant markers of cancer stem cells indicate a poor prognosis in hepatocellular carcinoma patients: a meta-analysis.
    Ma YC; Yang JY; Yan LN
    Eur J Gastroenterol Hepatol; 2013 Sep; 25(9):1007-16. PubMed ID: 23478672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Road to stemness in hepatocellular carcinoma.
    Flores-Téllez TN; Villa-Treviño S; Piña-Vázquez C
    World J Gastroenterol; 2017 Oct; 23(37):6750-6776. PubMed ID: 29085221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer stem cells in osteosarcoma.
    Brown HK; Tellez-Gabriel M; Heymann D
    Cancer Lett; 2017 Feb; 386():189-195. PubMed ID: 27894960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
    Yan Y; Zuo X; Wei D
    Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Research progression in colorectal cancer stem cells].
    Wu TY; Cui L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):297-300. PubMed ID: 23536355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer stem cells (CSCs), cervical CSCs and targeted therapies.
    Huang R; Rofstad EK
    Oncotarget; 2017 May; 8(21):35351-35367. PubMed ID: 27343550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer.
    Zhou P; Li B; Liu F; Zhang M; Wang Q; Liu Y; Yao Y; Li D
    Mol Cancer; 2017 Feb; 16(1):52. PubMed ID: 28245823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.